Yu-Fen Chang

CEO
LumiSTAR Biotechnology, Inc.

Dr. Chang worked on projects involving the development of a variety of luminescent and fluorescent protein-based indicators during her PhD, which can be used for cellular dynamics measurements and real-time in vivo tracking. In 2011, she was awarded the Japanese Society for Promotion of Science (JSPS) fellowship to incorporate these indicators into the development of advanced imaging technology for measuring cellular function. Her research results were published in several high-impact journals. Subsequently, she received a research grant from BHF (2013-2016) to support her research at John Radcliffe Hospital in Oxford University, where she integrated the developed technologies into iPSC applications for drug screening and precision medicine. In 2016, she founded LumiSTAR Biotechnology and led the company in the development of high-throughput screening platforms for drug discovery and iPSC-associated cell therapy.